SEC Tracker
Get the app

Quest Diagnostics DGX

Robert B Carter (Director) reported 10 DGX at $235.93, worth $2K

Form
4
Filed
Importance
Routine
  1. Robert B Carter acquired 10 shares on Oct 21, 2026
  2. Shares acquired via dividend reinvestment plan
  3. Carter owns 3,874 shares
  4. Transaction price was $235.93 per share

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Quest Diagnostics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Labcorp Holdings LH public float $21.7B, Jun 30, 2025
  2. Natera NTRA public float $21.8B, Jun 30, 2025
  3. Exact Sciences EXAS public float $10.0B, Jun 30, 2025
  4. Guardant Health GH public float $6.2B, Jun 30, 2025
  5. RadNet RDNT public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.